HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Becq, F. Articles by Hanrahan, J. W. Search for Related Content PubMed PubMed Citation Articles by Becq, F. Articles by Hanrahan, J. W. Social Bookmarking                      What's this?

Volume 271, Number 27, Issue of July 5, 1996 pp. 16171-16179
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

cAMP- and Ca²⁺-independent Activation of Cystic Fibrosis Transmembrane Conductance Regulator Channels by Phenylimidazothiazole Drugs

(Received for publication, February 15, 1996)

Frédéric Becq ^§ , Bernard Verrier ^§ , Xiu-Bao Chang , John R. Riordan and John W. Hanrahan

From the  Department of Physiology, McGill University, 3655 Drummond Street, Montréal, Québec Canada H3G 1Y6, ^§ INSERM U270, Faculté de médecine nord, boulevard P. Dramard, 13326 Marseille, France, and the  S. C. Johnson Medical Research Center, Mayo Clinic Scottsdale, Scottsdale, Arizona 85259

Patch-clamp, iodide efflux, and biochemical techniques were used to evaluate the ability of phenylimidazothiazoles to open normal and mutated cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels and to investigate the mechanism of activation. As reported previously for bromotetramisole, levamisole activated wild-type CFTR channels stably expressed in Chinese hamster ovary cells in the absence of other secretagogues and without elevating intracellular cAMP or calcium. The protein kinase A (PKA) inhibitor N - (2-(p-bromocinnamylamino)ethyl)-5-isoquinolinesul-fonamide abolished activation by forskolin but only partially inhibited stimulation by levamisole, suggesting the involvement of other kinases. CFTR channels bearing mutations at multiple phosphorylation sites, in the membrane domains, and in the first nucleotide binding domain (including the disease-causing mutations G551D and F508) all responded to phenylimidazothiazoles. Moreover, levamisole and bromotetramisole increased the activity of wild-type and mutant channels already exposed to PKA + MgATP, consistent with the inhibition of a constitutive, membrane-associated phosphatase activity. We conclude that phenylimidazothiazole drugs can open normal and mutated CFTR channels by stabilization of phosphoforms of CFTR that are produced by basal activity of PKA and alternative protein kinases. If similar stimulation is observed in humans in vivo, phenylimidazothiazoles may be useful in the development of pharmacological therapies for cystic fibrosis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. P. Joy and E. A. Cowley 8-iso-PGE2 Stimulates Anion Efflux from Airway Epithelial Cells via the EP4 Prostanoid Receptor Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 143 - 152. [Abstract] [Full Text] [PDF]

				S. G. Bompadre, Y. Sohma, M. Li, and T.-C. Hwang G551D and G1349D, Two CF-associated Mutations in the Signature Sequences of CFTR, Exhibit Distinct Gating Defects J. Gen. Physiol., March 26, 2007; 129(4): 285 - 298. [Abstract] [Full Text] [PDF]

				K. Kunzelmann and M. Mall Electrolyte Transport in the Mammalian Colon: Mechanisms and Implications for Disease Physiol Rev, January 1, 2002; 82(1): 245 - 289. [Abstract] [Full Text] [PDF]

				R. Derand, L. Bulteau-Pignoux, Y. Mettey, O. Zegarra-Moran, L. D. Howell, C. Randak, L. J. V. Galietta, J. A. Cohn, C. Norez, L. Romio, et al. Activation of G551D CFTR channel with MPB-91: regulation by ATPase activity and phosphorylation Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1657 - C1666. [Abstract] [Full Text] [PDF]

				L. V. J. Galietta, S. Jayaraman, and A. S. Verkman Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1734 - C1742. [Abstract] [Full Text] [PDF]

				L. Bulteau, R. Derand, Y. Mettey, T. Metaye, M. R. Morris, C. M. McNeilly, C. Folli, L. J. V. Galietta, O. Zegarra-Moran, M. M. C. Pereira, et al. Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1925 - C1937. [Abstract] [Full Text] [PDF]

				J. Luo, T. Zhu, A. Evagelidis, M. D. Pato, and J. W. Hanrahan Role of protein phosphatases in the activation of CFTR (ABCC7) by genistein and bromotetramisole Am J Physiol Cell Physiol, July 1, 2000; 279(1): C108 - C119. [Abstract] [Full Text] [PDF]

				S. Herzig and J. Neumann Effects of Serine/Threonine Protein Phosphatases on Ion Channels in Excitable Membranes Physiol Rev, January 1, 2000; 80(1): 173 - 210. [Abstract] [Full Text] [PDF]

				D. Duan, L. Ye, F. Britton, L. J Miller, J. Yamazaki, B. Horowitz, and J. R Hume Purinoceptor-coupled Cl- channels in mouse heart: a novel, alternative pathway for CFTR regulation J. Physiol., November 15, 1999; 521(1): 43 - 56. [Abstract] [Full Text] [PDF]

				W. Su, B. E. Shmukler, M. N. Chernova, A. K. Stuart-Tilley, L. de Franceschi, C. Brugnara, and S. L. Alper Mouse K-Cl cotransporter KCC1: cloning, mapping, pathological expression, and functional regulation Am J Physiol Cell Physiol, November 1, 1999; 277(5): C899 - C912. [Abstract] [Full Text] [PDF]

				T. Zhu, D. Dahan, A. Evagelidis, S.-X. Zheng, J. Luo, and J. W. Hanrahan Association of Cystic Fibrosis Transmembrane Conductance Regulator and Protein Phosphatase 2C J. Biol. Chem., October 8, 1999; 274(41): 29102 - 29107. [Abstract] [Full Text] [PDF]

				F. Becq, Y. Mettey, M. A. Gray, L. J. V. Galietta, R. L. Dormer, M. Merten, T. Metaye, V. Chappe, C. Marvingt-Mounir, O. Zegarra-Moran, et al. Development of Substituted Benzo[c]quinolizinium Compounds as Novel Activators of the Cystic Fibrosis Chloride Channel J. Biol. Chem., September 24, 1999; 274(39): 27415 - 27425. [Abstract] [Full Text] [PDF]

				B. D. SCHULTZ, A. K. SINGH, D. C. DEVOR, and R. J. BRIDGES Pharmacology of CFTR Chloride Channel Activity Physiol Rev, January 1, 1999; 79(1): 109 - 144. [Abstract] [Full Text] [PDF]

				B. Illek and H. Fischer Flavonoids stimulate Cl conductance of human airway epithelium in vitro and in vivo Am J Physiol Lung Cell Mol Physiol, November 1, 1998; 275(5): L902 - L910. [Abstract] [Full Text] [PDF]

				K A Lansdell, J F Kidd, S J Delaney, B J Wainwright, and D N Sheppard Regulation of murine cystic fibrosis transmembrane conductance regulator Cl- channels expressed in Chinese hamster ovary cells J. Physiol., November 1, 1998; 512(3): 751 - 764. [Abstract] [Full Text] [PDF]

				J. Luo, M. D. Pato, J. R. Riordan, and J. W. Hanrahan Differential regulation of single CFTR channels by PP2C, PP2A, and other phosphatases Am J Physiol Cell Physiol, May 1, 1998; 274(5): C1397 - C1410. [Abstract] [Full Text] [PDF]

				Y. Hamon, M.-F. Luciani, F. Becq, B. Verrier, A. Rubartelli, and G. Chimini Interleukin-1beta Secretion Is Impaired by Inhibitors of the Atp Binding Cassette Transporter, ABC1 Blood, October 15, 1997; 90(8): 2911 - 2915. [Abstract] [Full Text] [PDF]

				F. Becq, Y. Hamon, A. Bajetto, M. Gola, B. Verrier, and G. Chimini ABC1, an ATP Binding Cassette Transporter Required for Phagocytosis of Apoptotic Cells, Generates a Regulated Anion Flux after Expression in Xenopus laevis Oocytes J. Biol. Chem., January 31, 1997; 272(5): 2695 - 2699. [Abstract] [Full Text] [PDF]